Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions

ogarawo.wordpress.com
"Enabling our partners to maintai n clinical viability and provide valus to the patients they serve is critical to our mission during thesde challengingeconomic times. It is, imperative that we find a way to offe r our customersboth high-quality solutionsw and access to advanced technologies," said , chiec executive officer, Molecular Siemens Healthcare. "Though we've recently made some progressain U.S. imaging reimbursement policies, we need to furthed develop evidence-based data on a global so that we can continue to prov e the clinical and financial efficacy of molecular imagint technology as a valuable assetto detect, stage and monitof disease.
" As part of Siemens Molecular Imaging's commitment to innovation and access, it has recently releaseed several new systems into the PET-C T and SPECT-CT markets that allow facilities with limitef budgets, or those under financiaol constraints, to provide molecular imaging technology to theire patients: -- The Biograph mCT, the world's first moleculaf CT, will be shown at SNM for the firsty time. It enables facilities to serve both the nuclear medicins and the radiology departmentr withone system. It achievex this duality through the integration of powerful PET andCT technologies, offeringh High-Definition PET, time-of-flight technology, and CT configurationxs up to 128 slices.
Biograpjh mCT is ultra-efficient, offering institutions cutting-edge technology, optimukm patient care solutions and potential for increasede returnon investment. -- Siemens Biograph(TM) TruePoint 16-slice PET-CT is the latest addition to the Biograph family ofclinica scanners. This affordable and reliable imaginyg system has highperformance capabilities, including HD-PETr and routine, 10-minute whole-bodyy imaging. Biograph 16 is also mobile-ready, equipperd to maximize on-location patient throughput and servemultiplw communities.
-- Siemens family of SPECT and SPECT-CT scanner is flexible enough to meet the changingh needs of any imaging Symbia E, and Symbia S and T are economica yet powerful points of entry into SPECTf and SPECT-CT imaging for facilities that currentl do not offer molecular imaging or for facilitiezs with a limited budget. Now available with a broad rangwe of specialtydiagnostic tools, Symbiaz systems can be used for cardiology, neurology, and general imaging satisfying the needs of most facilities. Symbiaa S systems limit obsolescence by offering institutionsa future-ready system that is field-upgradeabled to diagnostic SPECT-CT.
-- New solutions in system applicationd that will be showm at SNM 2009 in Toronto includw anew thin-client solution for SPECT Symbia(R).net. This new applicatiob allows for increased workflow ease of use and portabilityyfor users. -- PETNET Solutions, a wholly-ownedf subsidiary of Siemens MedicalSolutions USA, operates the largest PET radiopharmacy networo with more than 52 molecular imaginh radiopharmacies and distribution centers at multiple worldwidew locations. With a network of PETNET guarantees reliable dose delivert to meet the needsof hospitals, and research facilities.
Siemens PETNET operations have strategically expandee to include international locations and to providr SPECT radiopharmaceuticals through an agreementr with CovidienMedical Imaging, further developing its PET and SPECTr coverage. As the global economicx crisis continues, and the healthcared environment continuesto evolve, Siemens is committed to offerinh the most advantageous and innovative systems at the most cost-efficient pricew points. The Siemens Healthcare Sectod is one ofthe world'x largest suppliers to the healthcarwe industry.
The company is a renownedf medical solutions provider with core competence and innovatived strength in diagnostic and therapeutic technologies as well as inknowledger engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the firstt integratedhealthcare company, bringing togethere imaging and lab diagnostics, therapy, and healthcarwe information technology solutions, supplemented by consulting and support Siemens Healthcare delivers solutions acroses the entire continuum of care - from preventiohn and early detection, to diagnosis, therapy and care.
Additionally, Siemenss Healthcare is the global market leader in innovativ ehearing instruments. The company employs around 49,00o people worldwide and operates in 130 In the fiscal year2008 (Sept. 30), Siemensx Healthcare reported sales ofeuro 11.2 billion, ordere of euro 11.8 billion, and Sector profitf of euro 1.2 billion. Further information can be founrd byvisiting .